Wedbush Securities Inc Axsome Therapeutics, Inc. Transaction History

Wedbush Securities Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$65.72 - $80.5 $228,639 - $280,059	-3,479 Reduced 41.93%	4,818 $388,000
Q1 2024 May 14, 2024	SELL	$69.39 - $97.64 $3,330 - $4,686	-48 Reduced 0.58%	8,297 $662,000
Q4 2023 Feb 12, 2024	BUY	$57.42 - $83.61 $70,339 - $102,422	1,225 Added 17.21%	8,345 $664,000
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $493,060 - $585,335	7,120 New	7,120 $498,000

325

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.73B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.